메뉴 건너뛰기




Volumn 95, Issue 5, 2009, Pages 422-429

The management of atrial fibrillation after cardiac surgery

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CIMETIDINE; DIGOXIN; DILTIAZEM; ESMOLOL; FENTANYL; FIBRIC ACID DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROLIDE; METOPROLOL; METOPROLOL TARTRATE; MEVINOLIN; PHENYTOIN; PLACEBO; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIMVASTATIN; SOTALOL; THEOPHYLLINE; TIMOLOL; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

EID: 61949141344     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.132795     Document Type: Review
Times cited : (47)

References (14)
  • 1
    • 1842831357 scopus 로고    scopus 로고
    • Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9. ▶ A large, multicentre, international study demonstrating clinical factors associated with increased risk of postoperative AF and its consequences.
    • Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9. ▶ A large, multicentre, international study demonstrating clinical factors associated with increased risk of postoperative AF and its consequences.
  • 2
    • 0034724433 scopus 로고    scopus 로고
    • Zaman AG, Archbold A, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000;101:1403-8. ▶ This study demonstrated that, along with age, a signal average P wave duration of >155 ms was associated with a higher incidence of postoperative AF.
    • Zaman AG, Archbold A, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000;101:1403-8. ▶ This study demonstrated that, along with age, a signal average P wave duration of >155 ms was associated with a higher incidence of postoperative AF.
  • 3
    • 1342265931 scopus 로고    scopus 로고
    • Biphasic versus monophasic shock waveform for the conversion of atrial fibrillation
    • A review of the data on the comparative efficacy of defibrillation using monophasic versus biphasic shock waveforms, ▶
    • Rho RW, Page RL. Biphasic versus monophasic shock waveform for the conversion of atrial fibrillation. Card Electrophysiol Rev 2003;7:290-1. ▶ A review of the data on the comparative efficacy of defibrillation using monophasic versus biphasic shock waveforms.
    • (2003) Card Electrophysiol Rev , vol.7 , pp. 290-291
    • Rho, R.W.1    Page, R.L.2
  • 4
    • 0034983118 scopus 로고    scopus 로고
    • Delle KG, Geppert A, Neunteufl T, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001;29:1149-53. ▶ Intravenous amiodarone is an effective rate controlling agent among critically ill patients compared to intravenous diltiazem.
    • Delle KG, Geppert A, Neunteufl T, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001;29:1149-53. ▶ Intravenous amiodarone is an effective rate controlling agent among critically ill patients compared to intravenous diltiazem.
  • 5
    • 33845328414 scopus 로고    scopus 로고
    • Interventions for the prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis
    • Burgess DC, Kilborn MJ, Keech AC. Interventions for the prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 2006;27:2846-57.
    • (2006) Eur Heart J , vol.27 , pp. 2846-2857
    • Burgess, D.C.1    Kilborn, M.J.2    Keech, A.C.3
  • 6
    • 85120091904 scopus 로고    scopus 로고
    • Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006;48;e149-246. ▶ The 2006 guidelines for the management of AF which include evidence of agents efficacious in primary and secondary prevention of postoperative AF.
    • Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006;48;e149-246. ▶ The 2006 guidelines for the management of AF which include evidence of agents efficacious in primary and secondary prevention of postoperative AF.
  • 7
    • 0031468254 scopus 로고    scopus 로고
    • Daoud EG, Stricker SA, Ching Man K, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-91. ▶ A randomised study demonstrating that oral amiodarone (600 mg/day) started a minimum of 7 days preoperatively and continued at 200 mg per day postoperatively until discharge significantly reduced the incidence of postoperative AF after cardiac surgery. 57% of patients in this study had concomitant valve surgery.
    • Daoud EG, Stricker SA, Ching Man K, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-91. ▶ A randomised study demonstrating that oral amiodarone (600 mg/day) started a minimum of 7 days preoperatively and continued at 200 mg per day postoperatively until discharge significantly reduced the incidence of postoperative AF after cardiac surgery. 57% of patients in this study had concomitant valve surgery.
  • 8
    • 85136381854 scopus 로고    scopus 로고
    • Mitchell LB, Exner DV, Wyse GD, et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement or repair. PAPABEAR: a randomized controlled trial. JAMA 2005;294:3093-100. ▶ A randomised study demonstrating a significant reduction in postoperative AF with 13 days of amiodarone initiated 6 days preoperatively. A significant reduction in AF was demonstrated in several subsets of patients including young patients, elderly patients (>65 years), and patients on BBs. All patients had valve surgery with or without coronary artery bypass grafting.
    • Mitchell LB, Exner DV, Wyse GD, et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement or repair. PAPABEAR: a randomized controlled trial. JAMA 2005;294:3093-100. ▶ A randomised study demonstrating a significant reduction in postoperative AF with 13 days of amiodarone initiated 6 days preoperatively. A significant reduction in AF was demonstrated in several subsets of patients including young patients, elderly patients (>65 years), and patients on BBs. All patients had valve surgery with or without coronary artery bypass grafting.
  • 9
    • 0041915883 scopus 로고    scopus 로고
    • White MC, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003;108:II-200-6. ▶ This study demonstrated that intravenous amiodarone initiated within 6 h after cardiac surgery and continued for 4 days postoperatively (total dose 4800 mg intravenously) significantly decreased the incidence of postoperative AF. No significant difference in AF was noted with bi-atrial pacing.
    • White MC, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003;108:II-200-6. ▶ This study demonstrated that intravenous amiodarone initiated within 6 h after cardiac surgery and continued for 4 days postoperatively (total dose 4800 mg intravenously) significantly decreased the incidence of postoperative AF. No significant difference in AF was noted with bi-atrial pacing.
  • 10
    • 34248398359 scopus 로고    scopus 로고
    • Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: A propensity-matched analysis
    • Aerra V, Kuduvalli M, Moloto AN, et al. Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis. J Cardiothoracic Surg 2006;1:6-11.
    • (2006) J Cardiothoracic Surg , vol.1 , pp. 6-11
    • Aerra, V.1    Kuduvalli, M.2    Moloto, A.N.3
  • 11
    • 0343471391 scopus 로고    scopus 로고
    • Pfisterer ME, Koter-Weber UCD, Huber M, et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. Ann Thorac Surgery 1997;64:1113-9. ▶ A randomised study demonstrating that sotalol 80 mg orally twice daily started 2 h before elective cardiac surgery significantly (and continued for 3 months postoperatively) decreased the incidence of postoperative AF among patients undergoing CABG surgery (n = 220) and aortic valve replacement ± CABG (n = 35).
    • Pfisterer ME, Koter-Weber UCD, Huber M, et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. Ann Thorac Surgery 1997;64:1113-9. ▶ A randomised study demonstrating that sotalol 80 mg orally twice daily started 2 h before elective cardiac surgery significantly (and continued for 3 months postoperatively) decreased the incidence of postoperative AF among patients undergoing CABG surgery (n = 220) and aortic valve replacement ± CABG (n = 35).
  • 12
    • 33749505716 scopus 로고    scopus 로고
    • Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 study
    • Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 study. Circulation 2006;114:1455-61.
    • (2006) Circulation , vol.114 , pp. 1455-1461
    • Patti, G.1    Chello, M.2    Candura, D.3
  • 13
    • 21044453770 scopus 로고    scopus 로고
    • N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial
    • Calo L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005;45:1723-8.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1723-1728
    • Calo, L.1    Bianconi, L.2    Colivicchi, F.3
  • 14
    • 21744446877 scopus 로고    scopus 로고
    • The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trial
    • Prasongskarn K, Abel JG, Jamieson WR, et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 2005;130:93-8.
    • (2005) J Thorac Cardiovasc Surg , vol.130 , pp. 93-98
    • Prasongskarn, K.1    Abel, J.G.2    Jamieson, W.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.